Industry: Chemical & Material
Published Date: 2026-07-14
Pages: 145 Pages
Report ld: 6892996
Request Sample
Customized Report
The global market for Alogliptin Benzoate Reagent was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Alogliptin is an orally bioavailable dipeptidyl peptidase 4 (DPP-4) inhibitor that is selective for DPP-4 over DPP-2, DPP-8, DPP-9, prolyl endopeptidase, fibroblast activation protein (FAP), and tryptase.
The North American market for Alogliptin Benzoate Reagent was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.
The Asia-Pacific market for Alogliptin Benzoate Reagent was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.
The European market for Alogliptin Benzoate Reagent was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.
The global key companies in the Alogliptin Benzoate Reagent market include BioVision, Biosynth Carbosynth, LGC, Cayman Chemical, BOC Sciences, AbMole, APExBIO Technology, Selleck Chemicals, SimSon Pharma, AK Scientific, etc. In 2025, the five largest players accounted for approximately % of revenue.
This report provides a comprehensive view of the global market for Alogliptin Benzoate Reagent, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Alogliptin Benzoate Reagent market size, estimations, and forecasts are presented in terms of sales volume (Kg) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Alogliptin Benzoate Reagent.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Alogliptin Benzoate Reagent manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Alogliptin Benzoate Reagent sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Alogliptin Benzoate Reagent sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Alogliptin Benzoate Reagent Product Introduction
1.2 Global Alogliptin Benzoate Reagent Market Size Forecast
1.2.1 Global Alogliptin Benzoate Reagent Sales Value (2021–2032)
1.2.2 Global Alogliptin Benzoate Reagent Sales Volume (2021–2032)
1.2.3 Global Alogliptin Benzoate Reagent Sales Price (2021–2032)
1.3 Alogliptin Benzoate Reagent Market Trends & Drivers
1.3.1 Alogliptin Benzoate Reagent Industry Trends
1.3.2 Alogliptin Benzoate Reagent Market Drivers & Opportunities
1.3.3 Alogliptin Benzoate Reagent Market Challenges
1.3.4 Alogliptin Benzoate Reagent Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Alogliptin Benzoate Reagent Players Revenue Ranking (2025)
2.2 Global Alogliptin Benzoate Reagent Revenue by Company (2021–2026)
2.3 Global Alogliptin Benzoate Reagent Sales Volume Ranking of Players (2025)
2.4 Global Alogliptin Benzoate Reagent Sales Volume by Company (2021–2026)
2.5 Global Alogliptin Benzoate Reagent Average Price by Company (2021–2026)
2.6 Key Manufacturers Alogliptin Benzoate Reagent Manufacturing Base and Headquarters
2.7 Key Manufacturers Alogliptin Benzoate Reagent Product Offerings
2.8 Key Manufacturers Start of Mass Production of Alogliptin Benzoate Reagent
2.9 Alogliptin Benzoate Reagent Market Competitive Analysis
2.9.1 Alogliptin Benzoate Reagent Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Alogliptin Benzoate Reagent Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Alogliptin Benzoate Reagent revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Alogliptin Benzoate Reagent Market Classification
3.1 Introduction by Type
3.1.1 Min Purity Less Than 98%
3.1.2 Min Purity 98%-99%
3.1.3 Min Purity More Than 99%
3.1.4 Global Alogliptin Benzoate Reagent Sales Value by Type
3.1.4.1 Global Alogliptin Benzoate Reagent Sales Value by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Alogliptin Benzoate Reagent Sales Value, by Type (2021–2032)
3.1.4.3 Global Alogliptin Benzoate Reagent Sales Value, by Type (%), 2021–2032
3.1.5 Global Alogliptin Benzoate Reagent Sales Volume by Type
3.1.5.1 Global Alogliptin Benzoate Reagent Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.5.2 Global Alogliptin Benzoate Reagent Sales Volume, by Type (2021–2032)
3.1.5.3 Global Alogliptin Benzoate Reagent Sales Volume, by Type (%), 2021–2032
3.1.6 Global Alogliptin Benzoate Reagent Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Research
4.1.2 Pharmaceutical
4.2 Global Alogliptin Benzoate Reagent Sales Value by Application
4.2.1 Global Alogliptin Benzoate Reagent Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Alogliptin Benzoate Reagent Sales Value, by Application (2021–2032)
4.2.3 Global Alogliptin Benzoate Reagent Sales Value, by Application (%), 2021–2032
4.3 Global Alogliptin Benzoate Reagent Sales Volume by Application
4.3.1 Global Alogliptin Benzoate Reagent Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Alogliptin Benzoate Reagent Sales Volume, by Application (2021–2032)
4.3.3 Global Alogliptin Benzoate Reagent Sales Volume, by Application (%), 2021–2032
4.4 Global Alogliptin Benzoate Reagent Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Alogliptin Benzoate Reagent Sales Value by Region
5.1.1 Global Alogliptin Benzoate Reagent Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Alogliptin Benzoate Reagent Sales Value by Region (2021–2026)
5.1.3 Global Alogliptin Benzoate Reagent Sales Value by Region (2027–2032)
5.1.4 Global Alogliptin Benzoate Reagent Sales Value by Region (%), 2021–2032
5.2 Global Alogliptin Benzoate Reagent Sales Volume by Region
5.2.1 Global Alogliptin Benzoate Reagent Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Alogliptin Benzoate Reagent Sales Volume by Region (2021–2026)
5.2.3 Global Alogliptin Benzoate Reagent Sales Volume by Region (2027–2032)
5.2.4 Global Alogliptin Benzoate Reagent Sales Volume by Region (%), 2021–2032
5.3 Global Alogliptin Benzoate Reagent Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Alogliptin Benzoate Reagent Sales Value, 2021–2032
5.4.2 North America Alogliptin Benzoate Reagent Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Alogliptin Benzoate Reagent Sales Value, 2021–2032
5.5.2 Europe Alogliptin Benzoate Reagent Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Alogliptin Benzoate Reagent Sales Value, 2021–2032
5.6.2 Asia Pacific Alogliptin Benzoate Reagent Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Alogliptin Benzoate Reagent Sales Value, 2021–2032
5.7.2 South America Alogliptin Benzoate Reagent Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Alogliptin Benzoate Reagent Sales Value, 2021–2032
5.8.2 Middle East & Africa Alogliptin Benzoate Reagent Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Alogliptin Benzoate Reagent Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Alogliptin Benzoate Reagent Sales Value and Sales Volume
6.2.1 Key Countries/Regions Alogliptin Benzoate Reagent Sales Value, 2021–2032
6.2.2 Key Countries/Regions Alogliptin Benzoate Reagent Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Alogliptin Benzoate Reagent Sales Value, 2021–2032
6.3.2 United States Alogliptin Benzoate Reagent Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Alogliptin Benzoate Reagent Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Alogliptin Benzoate Reagent Sales Value, 2021–2032
6.4.2 Europe Alogliptin Benzoate Reagent Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Alogliptin Benzoate Reagent Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Alogliptin Benzoate Reagent Sales Value, 2021–2032
6.5.2 China Alogliptin Benzoate Reagent Sales Value by Type (%), 2025 vs 2032
6.5.3 China Alogliptin Benzoate Reagent Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Alogliptin Benzoate Reagent Sales Value, 2021–2032
6.6.2 Japan Alogliptin Benzoate Reagent Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Alogliptin Benzoate Reagent Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Alogliptin Benzoate Reagent Sales Value, 2021–2032
6.7.2 South Korea Alogliptin Benzoate Reagent Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Alogliptin Benzoate Reagent Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Alogliptin Benzoate Reagent Sales Value, 2021–2032
6.8.2 Southeast Asia Alogliptin Benzoate Reagent Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Alogliptin Benzoate Reagent Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Alogliptin Benzoate Reagent Sales Value, 2021–2032
6.9.2 India Alogliptin Benzoate Reagent Sales Value by Type (%), 2025 vs 2032
6.9.3 India Alogliptin Benzoate Reagent Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 BioVision
7.1.1 BioVision Company Information
7.1.2 BioVision Introduction and Business Overview
7.1.3 BioVision Alogliptin Benzoate Reagent Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 BioVision Alogliptin Benzoate Reagent Product Offerings
7.1.5 BioVision Recent Developments
7.2 Biosynth Carbosynth
7.2.1 Biosynth Carbosynth Company Information
7.2.2 Biosynth Carbosynth Introduction and Business Overview
7.2.3 Biosynth Carbosynth Alogliptin Benzoate Reagent Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Biosynth Carbosynth Alogliptin Benzoate Reagent Product Offerings
7.2.5 Biosynth Carbosynth Recent Developments
7.3 LGC
7.3.1 LGC Company Information
7.3.2 LGC Introduction and Business Overview
7.3.3 LGC Alogliptin Benzoate Reagent Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 LGC Alogliptin Benzoate Reagent Product Offerings
7.3.5 LGC Recent Developments
7.4 Cayman Chemical
7.4.1 Cayman Chemical Company Information
7.4.2 Cayman Chemical Introduction and Business Overview
7.4.3 Cayman Chemical Alogliptin Benzoate Reagent Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Cayman Chemical Alogliptin Benzoate Reagent Product Offerings
7.4.5 Cayman Chemical Recent Developments
7.5 BOC Sciences
7.5.1 BOC Sciences Company Information
7.5.2 BOC Sciences Introduction and Business Overview
7.5.3 BOC Sciences Alogliptin Benzoate Reagent Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 BOC Sciences Alogliptin Benzoate Reagent Product Offerings
7.5.5 BOC Sciences Recent Developments
7.6 AbMole
7.6.1 AbMole Company Information
7.6.2 AbMole Introduction and Business Overview
7.6.3 AbMole Alogliptin Benzoate Reagent Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 AbMole Alogliptin Benzoate Reagent Product Offerings
7.6.5 AbMole Recent Developments
7.7 APExBIO Technology
7.7.1 APExBIO Technology Company Information
7.7.2 APExBIO Technology Introduction and Business Overview
7.7.3 APExBIO Technology Alogliptin Benzoate Reagent Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 APExBIO Technology Alogliptin Benzoate Reagent Product Offerings
7.7.5 APExBIO Technology Recent Developments
7.8 Selleck Chemicals
7.8.1 Selleck Chemicals Company Information
7.8.2 Selleck Chemicals Introduction and Business Overview
7.8.3 Selleck Chemicals Alogliptin Benzoate Reagent Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Selleck Chemicals Alogliptin Benzoate Reagent Product Offerings
7.8.5 Selleck Chemicals Recent Developments
7.9 SimSon Pharma
7.9.1 SimSon Pharma Company Information
7.9.2 SimSon Pharma Introduction and Business Overview
7.9.3 SimSon Pharma Alogliptin Benzoate Reagent Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 SimSon Pharma Alogliptin Benzoate Reagent Product Offerings
7.9.5 SimSon Pharma Recent Developments
7.10 AK Scientific
7.10.1 AK Scientific Company Information
7.10.2 AK Scientific Introduction and Business Overview
7.10.3 AK Scientific Alogliptin Benzoate Reagent Sales, Revenue, Price and Gross Margin (2021–2026)
7.10.4 AK Scientific Alogliptin Benzoate Reagent Product Offerings
7.10.5 AK Scientific Recent Developments
7.11 Target Molecule
7.11.1 Target Molecule Company Information
7.11.2 Target Molecule Introduction and Business Overview
7.11.3 Target Molecule Alogliptin Benzoate Reagent Sales, Revenue, Price and Gross Margin (2021–2026)
7.11.4 Target Molecule Alogliptin Benzoate Reagent Product Offerings
7.11.5 Target Molecule Recent Developments
7.12 Adooq Bioscience
7.12.1 Adooq Bioscience Company Information
7.12.2 Adooq Bioscience Introduction and Business Overview
7.12.3 Adooq Bioscience Alogliptin Benzoate Reagent Sales, Revenue, Price and Gross Margin (2021–2026)
7.12.4 Adooq Bioscience Alogliptin Benzoate Reagent Product Offerings
7.12.5 Adooq Bioscience Recent Developments
8 Industry Chain Analysis
8.1 Alogliptin Benzoate Reagent Industrial Chain
8.2 Alogliptin Benzoate Reagent Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Alogliptin Benzoate Reagent Sales Model
8.5.2 Sales Channels
8.5.3 Alogliptin Benzoate Reagent Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Alogliptin Benzoate Reagent market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 144
USD 2900.00
(Single User License)
The global Alogliptin Benzoate Reagent market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-22
Pages: 154
USD 4900.00
(Single User License)
The global market for Alogliptin Benzoate Reagent was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 123
USD 3950.00
(Single User License)
The global market for Alogliptin Benzoate Reagent was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-15
Pages: 101
USD 2900.00
(Single User License)
The global Alogliptin Benzoate Reagent market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 96
USD 4250.00
(Single User License)
Alogliptin is an orally bioavailable dipeptidyl peptidase 4 (DPP-4) inhibitor that is selective for DPP-4 over DPP-2, DPP-8, DPP-9, prolyl endopeptidase, fibroblast activation protein (FAP), and tryptase.
Published Date: 2024-04-07
Pages: 107
USD 4900.00
(Single User License)
Alogliptin is an orally bioavailable dipeptidyl peptidase 4 (DPP-4) inhibitor that is selective for DPP-4 over DPP-2, DPP-8, DPP-9, prolyl endopeptidase, fibroblast activation protein (FAP), and tryptase.
Published Date: 2024-02-19
Pages: 126
USD 3950.00
(Single User License)
Alogliptin is an orally bioavailable dipeptidyl peptidase 4 (DPP-4) inhibitor that is selective for DPP-4 over DPP-2, DPP-8, DPP-9, prolyl endopeptidase, fibroblast activation protein (FAP), and tryptase.
Published Date: 2024-01-12
Pages: 100
USD 2900.00
(Single User License)
The global Alogliptin Benzoate Reagent market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 144
The global Alogliptin Benzoate Reagent market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-22
Pages: 154
The global market for Alogliptin Benzoate Reagent was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 123
The global market for Alogliptin Benzoate Reagent was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-15
Pages: 101
The global Alogliptin Benzoate Reagent market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 96
Alogliptin is an orally bioavailable dipeptidyl peptidase 4 (DPP-4) inhibitor that is selective for DPP-4 over DPP-2, DPP-8, DPP-9, prolyl endopeptidase, fibroblast activation protein (FAP), and tryptase.
Published: 2024-04-07
Pages: 107
Alogliptin is an orally bioavailable dipeptidyl peptidase 4 (DPP-4) inhibitor that is selective for DPP-4 over DPP-2, DPP-8, DPP-9, prolyl endopeptidase, fibroblast activation protein (FAP), and tryptase.
Published: 2024-02-19
Pages: 126
Alogliptin is an orally bioavailable dipeptidyl peptidase 4 (DPP-4) inhibitor that is selective for DPP-4 over DPP-2, DPP-8, DPP-9, prolyl endopeptidase, fibroblast activation protein (FAP), and tryptase.
Published: 2024-01-12
Pages: 100
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now